Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Management of Male Fertility in Sickle Cell Disease before and after Hydroxycarbamide

Anoosha Habibi, MD, Elena Foïs, MD, Giovanna Cannas, MD, Jean-Antoine Ribeil, MD, Pierre Cougoul, MD, Emmanuelle Bernit, MD, Pablo Bartolucci, MD PhD, Frederic Galacteros, MDPhD

Blood (2017) 130 (Supplement 1): 2260.

https://doi.org/10.1182/blood.V130.Suppl_1.2260.2260

Published: 2017

Journal Articles

Abnormal Reproductive Measures and Seminal Plasma Findings in Men With Thalassemia Major (TM) and Iron Overload

Sylvia Titi Singer, MD, Jerry Wang, MD, Jung H Suh, PhD, David Killelea, PhD, Kristen Ivani, PhD, Olivia Oliveros, Qing Yuan, PhD, Elliott Vichinsky, MD, James Smith, MD

Blood (2013) 122 (21): 4707.

https://doi.org/10.1182/blood.V122.21.4707.4707

Published: 2013

Journal Articles

Gonadal Function in Survivors After Hodgkin Lymphoma (HL) Treatment within the German Hodgkin Study Group (GHSG) HD13–15 Trials.

Blood (2012) 120 (21): 2636.

https://doi.org/10.1182/blood.V120.21.2636.2636

Published: 2012

Journal Articles

Ongoing Chronic GvHD Is the Most Harmful Factor for Sperm Recovery In Male Survivors After Allogeneic HSCT Not Conditioned with TBI.

Alicia Rovo, MD, Maria Teresa van Lint, MD, Mahmoud Aljurf, MD, Nina Salooja, MD, Gülsan Sucak, MD, Ann Elizabeth Hunter, MD, Tan Swee Kim, MD, Gerard Socie, MD, Manuela Badoglio, Andre Tichelli, MD

Blood (2010) 116 (21): 3449.

https://doi.org/10.1182/blood.V116.21.3449.3449

Published: 2010

Journal Articles

Two Year Data from a Prospective Safety Study Analyzing the Consequences of Imatinib Mesylate Inhibition of Sensitive Kinases Other Than bcr-abl in Patients with Previously Untreated Chronic Phase CML.

John Francis Seymour, MBBS, PhD, Andrew Grigg, MB BS, John Reynolds, Ph D, Anthony P. Schwarer, MB BS PhD, Richard Hermann, MB BS, Kerry McDonald Taylor, MB BS, Kenneth Francis Bradstock, MB BS PhD, Anthony K. Mills, MB BS, Rachel Koelmeyer, BSc, Kevin Lynch, Timothy Hughes, MBBS MD

Blood (2006) 108 (11): 2147.

https://doi.org/10.1182/blood.V108.11.2147.2147

Published: 2006

NARROW

Management of Male Fertility in Sickle Cell Disease before and after Hydroxycarbamide

Abnormal Reproductive Measures and Seminal Plasma Findings in Men With Thalassemia Major (TM) and Iron Overload

Gonadal Function in Survivors After Hodgkin Lymphoma (HL) Treatment within the German Hodgkin Study Group (GHSG) HD13–15 Trials.

Ongoing Chronic GvHD Is the Most Harmful Factor for Sperm Recovery In Male Survivors After Allogeneic HSCT Not Conditioned with TBI.

Two Year Data from a Prospective Safety Study Analyzing the Consequences of Imatinib Mesylate Inhibition of Sensitive Kinases Other Than bcr-abl in Patients with Previously Untreated Chronic Phase CML.

Email alerts

ASH Publications

American Society of Hematology

Management of Male Fertility in Sickle Cell Disease before and after Hydroxycarbamide

Abnormal Reproductive Measures and Seminal Plasma Findings in Men With Thalassemia Major (TM) and Iron Overload

Gonadal Function in Survivors After Hodgkin Lymphoma (HL) Treatment within the German Hodgkin Study Group (GHSG) HD13–15 Trials.

Ongoing Chronic GvHD Is the Most Harmful Factor for Sperm Recovery In Male Survivors After Allogeneic HSCT Not Conditioned with TBI.

Two Year Data from a Prospective Safety Study Analyzing the Consequences of Imatinib Mesylate Inhibition of Sensitive Kinases Other Than bcr-abl in Patients with Previously Untreated Chronic Phase CML.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only